WHAT IS IMMERGE?
IMMERGE: STORMING IMMUNE MONOGENIC CONDITIONS THROUGH MULTIOMIC AND GENE EDITING APPROACHES
IMMERGE is a Doctoral Network funded by Marie Skłodowska-Curie Actions of the European Union’s Horizon Europe research and innovation Programme.
IMMERGE is a unique educational program at PhD level that takes a multidisciplinary approach, designed to provide specialized training to 13 Doctoral Candidates (DC) in the area of immunology, with a focus on Inborn Errors of Immunity (IEI), which will be supervised by international experts in the field.
IMMERGE is a collaborative initiative that unites leading experts from 10 European and International public and private institutions in the fields of immunology, genetics, epigenetics, proteomics, single cell omics, bioinformatics, and gene correction.
IMMERGE investigates how IEI impact on immune cell functions, using single cell analysis, multiomics and computational tools to understand modified cellular pathways. Our goal is to understand, model and correct IEIs through genetic interventions and pre-clinical models.
NEWS
13.03.2024
IMMERGE: Kick-Off Meeting and 1st Supervisory Board Meeting
The IMMERGE Management Team is thrilled to announce that the online Kick-Off Meeting and the 1st IMMERGE Supervisory Board Meeting of the Consortium took place on March 13th, 2024.
12.07.2023
Dr. Esteban Ballestar and Dr. José Luis Sardina, Group Leaders at the Josep Carreras Leukaemia Research Institute, will coordinate the IMMERGE project “Storming Immune Monogenic Conditions through Multiomic and Gene Editing Approaches”. This project is a Marie Skłodowska Curie Action Doctoral Network funded by the European Commission under the Horizon Europe framework programme. Its objective is to train 12 Doctoral candidates to become world-class experts and provide new answers to tackle primary immunodeficiency patients.
